Bristol Myers Squibb announced that the European Commission (EC) has granted approval to Abecma® (idecabtagene vicleucel; ide-cel) for the treatment of adult patients with relapsed and...
The U.S. Food and Drug Administration approved Lenmeldy, the first FDA-approved gene therapy indicated for the treatment of children with pre-symptomatic late infantile, pre-symptomatic...
Oversubscribed round propels company towards clinical trials and global market expansion, promising to extend organ preservation times and revolutionize healthcare.
X-Therma Inc., a biotechnology company...
Data Describing Activity of P-BCMA-ALLO1 in BCMA-Experienced Patients to be Presented at Upcoming AACR Meeting
Poseida Therapeutics, Inc., a clinical-stage cell and gene therapy company...
3D printing technology has revolutionized the manufacturing process across various industries, and the field of medicine is no exception. The ability to create three-dimensional...
